XML 122 R109.htm IDEA: XBRL DOCUMENT
v3.23.1

LONG-TERM INVESTMENTS - Equity method investments (Details) - CNY (¥) ¥ in Thousands | Dec. 31, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017
--- | --- | --- | --- | --- | --- | --- | ---
LONG-TERM INVESTMENTS |  |  |  |  |  |  |
Equity investments with readily determinable fair value | ¥ 51,524 |  | ¥ 51,524 |  |  |  |
Xi'an JiangyuanAndike Ltd. ("JYADK") |  |  |  |  |  |  |
LONG-TERM INVESTMENTS |  |  |  |  |  |  |
Equity interest in equity method investment | 29.70% |  | 29.70% |  |  |  |
Equity investments with readily determinable fair value | ¥ 10,496 |  | ¥ 12,468 |  |  |  |
Suzhou Shengshan Huiying Venture Capital Investment LLP. ("Suzhou Shengshan") |  |  |  |  |  |  |
LONG-TERM INVESTMENTS |  |  |  |  |  |  |
Equity interest in equity method investment | 5.15% |  | 5.15% | 5.15% | 5.15% | 5.41% | 8.13%
Equity investments with readily determinable fair value | ¥ 12,939 |  | ¥ 11,051 |  |  |  |
Zhejiang Marine Leasing Ltd |  |  |  |  |  |  |
LONG-TERM INVESTMENTS |  |  |  |  |  |  |
Equity interest in equity method investment | 20.00% |  | 20.00% |  |  |  |
Equity investments with readily determinable fair value | ¥ 179,231 |  | ¥ 167,044 |  |  |  |
Guangdong Hengjian Proton Medical Industry Co., Ltd ("Guangdong Hengjian") |  |  |  |  |  |  |
LONG-TERM INVESTMENTS |  |  |  |  |  |  |
Equity interest in equity method investment | 14.20% |  | 14.20% |  |  |  |
Equity investments with readily determinable fair value | ¥ 86,315 |  | ¥ 86,493 |  |  |  |
Shanghai Xinhe Enterprise Management Center (Limited Partnership) ("Shanghai Xinhe") |  |  |  |  |  |  |
LONG-TERM INVESTMENTS |  |  |  |  |  |  |
Equity interest in equity method investment | 99.99% | 99.00% | 0.00% |  |  |  |
Equity investments with readily determinable fair value | ¥ 45,005 |  | ¥ 0 |  |  |  |
Shanghai Changshengshu Management Co. LTD("Shanghai Changshengshu") |  |  |  |  |  |  |
LONG-TERM INVESTMENTS |  |  |  |  |  |  |
Equity interest in equity method investment | 20.00% |  | 0.00% |  |  |  |
Equity investments with readily determinable fair value | ¥ 1,968 |  | ¥ 0 |  |  |  |
Guangzhou Yicheng Biological Immune Technology Co. LTD("Guangzhou Yicheng") |  |  |  |  |  |  |
LONG-TERM INVESTMENTS |  |  |  |  |  |  |
Equity interest in equity method investment | 30.00% |  | 0.00% |  |  |  |
Equity investments with readily determinable fair value | ¥ 300 |  | ¥ 0 |  |  |  |
Equity interest owned by the group |  |  |  |  |  |  |
LONG-TERM INVESTMENTS |  |  |  |  |  |  |
Equity investments with readily determinable fair value | ¥ 336,254 |  | ¥ 277,056 |  |  |  |

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Fair value portion of investments accounted under the equity method. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 25 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126960272&loc=d3e32014-111567 + Details
Name: | us-gaap_EquityMethodInvestmentsFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ccm_XianJiangyuanAndikeLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ccm_SuzhouShengshanHuiyingVentureCapitalInvestmentLlpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ccm_ZhejiangMarineLeasingLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ccm_GuangdongHengjianProtonMedicalIndustryCo.LtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ccm_ShanghaiXinheEnterpriseManagementCenterLimitedPartnershipMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ccm_ShanghaiChangshengshuManagementCo.LtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ccm_GuangzhouYichengBiologicalImmuneTechnologyCo.LimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ccm_EquityInterestOwnedByGroupMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |